Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04753996

Characterization of Biliary Cell-derived Organoids From Bile of PSC and Non-PSC Patients

Status
Recruiting
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Accepted

Summary

The purpose of this research is to create a collection of bile, bile duct brushings and medical information from people with Primary Sclerosing Cholangitis (PSC) and controls to learn more about changes that occur in the liver.

Detailed description

The study will ask participants to provide bile and/or bile duct cytology brushings at time of endoscopic retrograde cholangiopancreatography (ERCP) or cholecystectomy (gallbladder removal). The bile and brushings will be used to generate and perpetuate bile-derived organoids using an established matrigel-based protocol. These organoids will then be used in downstream experiments to better understand disease-specific alterations to biological pathways informative of disease pathogenesis

Conditions

Timeline

Start date
2021-03-08
Primary completion
2035-01-01
Completion
2035-01-01
First posted
2021-02-15
Last updated
2026-02-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04753996. Inclusion in this directory is not an endorsement.

Characterization of Biliary Cell-derived Organoids From Bile of PSC and Non-PSC Patients (NCT04753996) · Clinical Trials Directory